Profile data is unavailable for this security.
About the company
Matricelf Ltd is an Israel-based company engaged in the biotechnology sector. The Company operates in the field of tissue engineering and regenerative medicine. The Firm develops a platform for autologous 3D printing of neutral human matrix, cells, tissues and organs implants. The implants are manufactured using cellular components originated from the patients themselves, to reduce potential immune response. The Company focuses on the treatment of spinal cord injury (SCI), but is also involved in developing treatment for additional medical conditions, including: Myocardial Infarction (MI), Parkinson’s disease and Age-related Macular Degeneration (AMD). Matricelf Ltd is a spin-out company from Tel Aviv University.
- Revenue in ILS (TTM)0.00
- Net income in ILS-13.83m
- Incorporated2019
- Employees--
- LocationMatricelf LtdGOLDA M'EIR 3NESS-ZIONA 7651713IsraelISR
- Fax+972 88609591
- Websitehttps://matricelf.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merchavia Holdings and Investments Ltd | 460.00k | -16.23m | 13.94m | 1.23k | -- | 0.4825 | -- | 30.31 | -3.87 | -3.87 | 0.0409 | 1.72 | 0.0121 | -- | 1.53 | 374.59 | -42.78 | -3.37 | -43.98 | -3.46 | -- | -- | -3,528.48 | -185.15 | -- | -0.1346 | 0.00 | -- | 90.08 | -10.25 | -349.99 | -- | 37.97 | -- |
| Nextage Therapeutics Ltd | 876.00k | -4.07m | 21.29m | -- | -- | -- | -- | 24.31 | -0.1396 | -0.1396 | 0.03 | -0.0958 | 0.672 | -- | 6.82 | -- | -322.44 | -188.94 | -- | -423.76 | 25.68 | 33.33 | -479.79 | -2,486.19 | -- | -18.46 | -- | -- | -- | 17.99 | 27.21 | -- | -- | -- |
| Kadimastem Ltd | 0.00 | -12.01m | 26.11m | 32.00 | -- | -- | -- | -- | -1.22 | -1.22 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -115.17 | -155.33 | -1,153.60 | -1,831.12 | -- | -- | -- | -- | -- | -9.44 | 3.22 | -- | -- | -- | 47.14 | -- | -50.73 | -- |
| Purple Biotech Ltd | 0.00 | -67.90m | 47.78m | 20.00 | -- | 0.3811 | -- | -- | -0.2679 | -0.2679 | 0.00 | 0.4086 | 0.00 | -- | -- | 0.00 | -40.57 | -37.24 | -47.99 | -41.28 | -- | -- | -- | -9,415.70 | -- | -- | 0.0098 | -- | -- | -- | 8.25 | -- | -28.45 | -- |
| X T L Biopharmaceuticals Ltd | 1.64m | -81.38m | 48.73m | 33.00 | -- | 0.599 | -- | 29.66 | -0.3695 | -0.3695 | 0.0075 | 0.1493 | 0.0192 | -- | 0.7012 | 49,784.54 | -94.96 | -53.17 | -111.98 | -59.10 | -- | -2.33 | -4,953.75 | -1,084.42 | -- | -- | 0.00 | -- | -85.80 | -- | -7.97 | -- | -53.12 | -- |
| Matricelf Ltd | 0.00 | -13.83m | 57.22m | -- | -- | 2.12 | -- | -- | -0.8777 | -0.8777 | 0.00 | 1.67 | 0.00 | -- | -- | -- | -39.69 | -- | -42.80 | -- | -- | -- | -- | -- | -- | -- | 0.0527 | -- | -- | -- | -10.77 | -- | -- | -- |
| DNA Group TR Ltd | 306.00k | -1.18m | 87.20m | 14.00 | -- | 1.10 | -- | 284.97 | -0.0088 | -0.0088 | 0.0025 | 0.6429 | 0.0038 | -- | 1.37 | 21,857.14 | -1.45 | -23.54 | -1.46 | -26.27 | -- | -- | -384.64 | -7,406.24 | -- | -- | 0.00 | -- | -45.36 | -- | 95.00 | -- | -- | -- |
| Bonus Biogroup Ltd | 0.00 | -28.84m | 178.69m | 58.00 | -- | 8.13 | -- | -- | -0.0675 | -0.0675 | 0.00 | 0.0188 | 0.00 | -- | -- | 0.00 | -54.73 | -76.10 | -63.36 | -97.19 | -- | -- | -- | -- | -- | -- | 0.331 | -- | -- | -- | 26.29 | -- | 19.30 | -- |
| BioLine RX Ltd | 42.18m | -177.85m | 208.43m | 79.00 | -- | 4.00 | -- | 4.94 | -0.184 | -0.184 | 0.042 | 0.0435 | 0.1939 | -- | 6.40 | 533,872.80 | -81.75 | -52.74 | -127.94 | -65.43 | 55.84 | -- | -421.69 | -3,501.79 | 1.05 | -519.43 | 0.4642 | -- | -- | -- | -142.93 | -- | -50.72 | -- |
Data as of Jul 16 2024. Currency figures normalised to Matricelf Ltd's reporting currency: Israeli Shekel ILS
0.64%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| KSM Mutual Funds Ltd.as of 30 Apr 2024 | 52.19k | 0.32% |
| Meitav Mutual Funds Ltd.as of 30 Apr 2024 | 33.72k | 0.21% |
| Migdal Mutual Funds Ltd.as of 30 Apr 2024 | 12.34k | 0.08% |
| Psagot Mutual Funds Ltd.as of 30 Apr 2024 | 3.19k | 0.02% |
| Harel Mutual Funds Ltd.as of 30 Apr 2024 | 1.07k | 0.01% |
More ▼
Data from 31 Mar 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
